Skip to main content

Table 3 Genome-wide association analysis of pancreatic cancer-related metabolites

From: Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohort

Metabolites

SNP

Position

EA

EAF

Mapped Gene

OR [CI]

p

HMDB0244373

Eicosa-11,14,17-trienoic acid

rs6731366

chr2:132891267 (GRCh38.p14)

A

0.053

NCKAP5

1.740 [0.833–3.633]

0.141

rs11860247

chr16:16071432 (GRCh38.p14)

A

0.086

ABCC1

1.016 [0.534–1.934]

0.960

rs201237448

chr3:157725970 (GRCh38.p14)

A

0.053

 

0.869 [0.388–1.944]

0.732

rs4541064

chr16:85230276 (GRCh38.p14)

C

0.487

GSE1

1.037 [0.615–1.748]

0.892

rs114089627

chr3:3658708 (GRCh38.p14)

A

0.016

 

1.106 [0.503–2.432]

0.802

rs138810234

chr4:161529556 (GRCh38.p14)

C

0.036

FSTL5

1.430 [0.834–2.450]

0.193

rs77806269

chr3:12881670 (GRCh38.p14)

T

0.023

LINC02022, LOC105376956

0.749 [0.363–1.548]

0.436

rs2370981

chr14:79402892 (GRCh38.p14)

G

0.017

NRXN3

0.371 [0.142–0.968]

0.043

rs117753991

chr16:77579192 (GRCh38.p14)

G

0.024

 

0.951 [0.518–1.748]

0.873

rs201592606

chr4:139691697 (GRCh38.p14)

G

0.050

MGST2

1.089 [0.683–1.738]

0.720

HMDB0000715

Kynurenic acid

rs73448444

chr13:28731007 (GRCh38.p14)

G

0.138

 

1.075 [0.614–1.883]

0.799

rs200475458

chr17:16403690–703 (GRCh38.p14)

C

0.110

 

0.833 [0.463–1.498]

0.541

rs187490

chr5:35045022 (GRCh38.p14)

G

0.311

AGXT2

1.256 [0.787–2.005]

0.339

rs604140

chr2:67422625 (GRCh38.p14)

C

0.050

 

1.734 [0.834–3.602]

0.140

rs78053646

chr12:231126 (GRCh38.p14)

T

0.166

SLC6A13, PARM1

1.233 [0.746–2.039]

0.414

rs890289

chr4:75,047,822 (GRCh38.p14)

A

0.054

LOC107986289

0.998 [0.481–2.070]

0.995

rs9908634

chr17:79431371 (GRCh38.p14)

T

0.062

RBFOX3

1.224 [0.603–2.485]

0.576

rs12909308

chr15:61777037 (GRCh38.p14)

T

0.284

 

1.223 [0.770–1.942]

0.393

rs10407389

chr19:36484416 (GRCh38.p14)

G

0.103

ZNF566

0.996 [0.559–1.775]

0.990

rs72747726

chr15:69,899,377 (GRCh38.p14)

G

0.238

 

1.093 [0.680–1.757]

0.712

HMDB0011741

γ-Glutamyl tyrosine

rs59519100

chr20:33868761 (GRCh38.p14)

T

0.166

 

1.701 [1.046–2.765]

0.032

rs193488

chr5:136703440 (GRCh38.p14)

G

0.053

 

1.920 [0.948–3.890]

0.070

rs202074299

chr13:90,574,203 (GRCh38.p14)

T

0.165

 

1.126 [0.689–1.839]

0.637

HMDB0002038

N(6)-Methyllysine

rs200559669

chr6:123584482 (GRCh38.p14)

C

0.481

TRDN

0.685 [0.415–1.131]

0.139

rs918171

chr19:3336541 (GRCh38.p14)

C

0.370

 

0.947 [0.599–1.499]

0.817

rs2374205

chr4:113984965 (GRCh38.p14)

G

0.143

LOC124900762

0.893 [0.523–1.524]

0.677

rs116931887

chr6:143808387 (GRCh38.p14)

C

0.384

PHACTR2

0.971 [0.612–1.241]

0.900

HMDB0011130

LysoPE(18:0/0:0)

rs11083238

chr18:27943526 (GRCh38.p14)

T

0.135

CDH2

1.299 [0.744–2.267]

0.358

rs6731366

chr2:132891267 (GRCh38.p14)

A

0.053

NCKAP5

1.329 [0.615–2.874]

0.469

rs12059514

chr1:102370790 (GRCh38.p14)

C

0.181

 

0.987 [0.571–1.706]

0.964

rs28565987

chr15:88048299 (GRCh38.p14)

A

0.097

NTRK3

0.829 [0.432–1.590]

0.573

rs2505110

chr10:30181971 (GRCh38.p14)

G

0.248

 

0.843 [0.514–1.384]

0.500

rs62525721

chr8:129066916 (GRCh38.p14)

T

0.052

 

0.986 [0.430–2.259]

0.973

rs8052560

chr16:88710834 (GRCh38.p14)

C

0.082

CTU2

1.391 [0.734–2.636]

0.312

rs117723718

chr4:40487925 (GRCh38.p14)

G

0.057

RBM47

1.050 [0.489–2.254]

0.901

rs28705703

chr6:167502412 (GRCh38.p14)

G

0.066

 

1.650 [0.823–3.306]

0.158

rs9829051

chr3:31491669 (GRCh38.p14)

G

0.122

 

1.149 [0.628–2.102]

0.652

rs375927045

chr7:16220625 (GRCh38.p14)

C

0.208

CRPPA

0.624 [0.370–1.052]

0.077

rs881433

chr18:44864508 (GRCh38.p14)

A

0.262

SETBP1

1.293 [0.799–2.092]

0.295

rs11164375

chr1:102083600 (GRCh38.p14)

T

0.080

 

2.194 [1.095–4.394]

0.027

rs117753153

chr3:24689035 (GRCh38.p14)

G

0.050

 

1.041 [0.446–2.427]

0.927

rs1923773

chr13:53176219 (GRCh38.p14)

G

0.148

 

0.999 [0.576–1.732]

0.996

rs141483946

chr11:13570434 (GRCh38.p14)

A

0.079

 

1.472 [0.751–2.884]

0.260

rs9345335

chr6:93188629 (GRCh38.p14)

G

0.400

 

0.999 [0.605–1.651]

0.998

rs78505433

chr15:49737092 (GRCh38.p14)

T

0.053

 

1.642 [0.761–3.547]

0.207

rs57966757

chr18:5919654 (GRCh38.p14)

A

0.076

LOC121725015

0.938 [0.477–1.844]

0.853

rs4727289

chr7:93397016 (GRCh38.p14)

G

0.120

 

0.743 [0.407–1.356]

0.333

rs55721115

chr14:34277292 (GRCh38.p14)

G

0.054

 

0.515 [0.212–1.250]

0.143

HMDB0304504

Trans-3′-hydroxy cotinine

rs74600139

chr5:44446171 (GRCh38.p14)

C

0.249

 

0.845 [0.531–1.344]

0.477

rs8100204

chr19:19282905 (GRCh38.p14)

A

0.201

SUGP1

0.763 [0.472–1.234]

0.270

rs148195640

chr20:59240551 (GRCh38.p14)

T

0.053

ZNF831

0.754 [0.435–1.306]

0.313

rs4308248

chr3:134302128 (GRCh38.p14)

G

0.129

 

0.729 [0.327–1.621]

0.438

HMDB0012273

Palmitic amide

rs13043798

chr20:23283897 (GRCh38.p14)

A

0.269

 

0.709 [0.446–1.127]

0.146

rs13132855

chr4:44399250 (GRCh38.p14)

A

0.085

KCTD8

1.038 [0.551–1.954]

0.908

rs7949816

chr11:60278427 (GRCh38.p14)

A

0.130

 

0.778 [0.453–1.338]

0.364

rs2724067

chr7:93831676 (GRCh38.p14)

A

0.246

 

0.877 [0.552–1.393]

0.579

rs149210546

chr4:8824426 (GRCh38.p14)

C

0.391

 

1.458 [0.896–2.375]

0.129

rs76582834

chr4:164383443 (GRCh38.p14)

C

0.076

MARCHF1

0.568 [0.280–1.152]

0.117

HMDB0000687

l-Leucine

rs76417681

chr2:61231241 (GRCh38.p14)

C

0.062

USP34

0.610 [0.271–1.371]

0.232

rs17684350

chr10:18374682 (GRCh38.p14)

C

0.080

CACNB2

1.597 [0.814–3.133]

0.173

rs55828915

chr1:207785790 (GRCh38.p14)

T

0.060

CD46

0.742 [0.335–1.642]

0.462

rs57192942

chr10:127846701 (GRCh38.p14)

T

0.265

 

1.415 [0.863–2.320]

0.169

rs72709073

chr9:69206346 (GRCh38.p14)

C

0.054

TJP2

0.749 [0.331–1.696]

0.488

rs7182182

chr15:54,330,440 (GRCh38.p14)

A

0.064

UNC13C

0.848 [0.395–1.822]

0.673

rs11525305

chr10:6632812 (GRCh38.p14)

A

0.073

LINC02648

1.365 [0.688–2.708]

0.373

rs74724211

chr19:44209431 (GRCh38.p14)

G

0.097

ZNF227

0.847 [0.447–1.605]

0.610

rs79500165

chr2:141763014 (GRCh38.p14)

T

0.056

LRP1B, LOC107985779

0.663 [0.271–1.626]

0.370

rs72805402

chr10:75306714 (GRCh38.p14)

A

0.152

ZNF503

2.150 [1.258–3.674]

0.005

rs687168

chr17:14441416 (GRCh38.p14)

C

0.172

 

1.281 [0.657–2.495]

0.467

rs13388819

chr2:64599202 (GRCh38.p14)

T

0.099

LOC105374773

1.278 [0.681–2.398]

0.445

rs77464636

chr7:2301325 (GRCh38.p14)

A

0.103

SNX8

0.85 [0.459–1.574]

0.605

rs7525555

chr1:202170575 (GRCh38.p14)

G

0.138

PTPRVP

0.747 [0.420–1.329]

0.321

rs7175639

chr15:50210373 (GRCh38.p14)

C

0.206

SLC27A2

1.005 [0.609–1.660]

0.983

rs117920703

chr9:34250372 (GRCh38.p14)

A

0.060

UBAP1

0.449 [0.185–1.093]

0.078

rs28438600

chr8:15523840 (GRCh38.p14)

A

0.050

 

0.598 [0.252–1.418]

0.243

rs17134252

chr11:99717399 (GRCh38.p14)

A

0.059

CNTN5

0.978 [0.448–2.133]

0.955

rs55870181

chr14:84615718 (GRCh38.p14)

T

0.272

 

1.821 [1.123–2.951]

0.015

rs147699000

chr22:44353381 (GRCh38.p14)

A

0.070

 

0.901 [0.428–1.899]

0.785

rs8074518

chr17:14443114 (GRCh38.p14)

G

0.338

 

0.970 [0.526–1.792]

0.924

rs73497629

chr9:100688200 (GRCh38.p14)

C

0.242

 

1.258 [0.768–2.060]

0.362

rs12429312

chr13:22915866 (GRCh38.p14)

A

0.212

LINC00621

0.908 [0.539–1.530]

0.717

rs149903005

chr13:66587358–64 (GRCh38.p14)

C

0.126

PCDH9, LOC105370247

1.133 [0.639–2.011]

0.669

HMDB0000448

Adipic acid

rs6057003

chr20:9908557 (GRCh38.p14)

C

0.179

 

0.853 [0.520–1.400]

0.529

rs10846689

chr12:124601819 (GRCh38.p14)

T

0.198

 

1.056 [0.610–1.826]

0.847

rs73608605

chr8:39240193 (GRCh38.p14)

G

0.086

ADAM32

1.357 [0.730–2.521]

0.334

rs12361624

chr11:30658520 (GRCh38.p14)

G

0.153

 

1.422 [0.859–2.354]

0.171

rs837465

chr12:124534405 (GRCh38.p14)

A

0.188

NCOR2

0.943 [0.539–1.647]

0.835

rs6964529

chr7:54293427 (GRCh38.p14)

C

0.085

 

1.064 [0.567–1.993]

0.848

rs6739384

chr2:56142078 (GRCh38.p14)

A

0.064

LOC105374690

0.527 [0.248–1.124]

0.097

rs9291437

chr4:22163632 (GRCh38.p14)

C

0.426

 

1.163 [0.710–1.907]

0.548

HMDB0013205

9-Decenoylcarnitine

rs117445640

chr4:179766591 (GRCh38.p14)

T

0.116

 

0.963 [0.556–1.669]

0.894

rs17116178

chr11:113956604 (GRCh38.p14)

T

0.107

 

0.787 [0.442–1.399]

0.414

rs2836817

chr21:39001801 (GRCh38.p14)

C

0.193

LINC02940

0.639 [0.390–1.049]

0.077

rs71364155

chr17:12218522 (GRCh38.p14)

T

0.380

 

1.101 [0.688–1.762]

0.688

rs1532216

chr12:99210187 (GRCh38.p14)

A

0.063

ANKS1B

1.186 [0.605–2.325]

0.619

HMDB0003759

5a-Pregnane-3,20-dione

rs74869776

chr12:30963077 (GRCh38.p14)

G

0.050

TSPAN11

0.716 [0.319–1.607]

0.418

rs79255083

chr4:66526962 (GRCh38.p14)

C

0.069

 

1.104 [0.561–2.173]

0.775

rs7760758

chr6:24036861 (GRCh38.p14)

A

0.062

 

0.636 [0.295–1.369]

0.247

rs9792660

chr9:29371008 (GRCh38.p14)

T

0.205

 

0.802 [0.497–1.295]

0.367

  1. Genome-wide association analysis of significant pancreatic cancer-related metabolites from XGBoost was performed. Significant associations (p ≤ 5 × 10–6) were presented. Exp(B) and p were derived from logistic regression of pancreatic cancer with adjusting sex. Values reported in bold are statistically significant in logistic regression evaluating association between pancreatic cancer and EA of SNP (p < 0.05)
  2. EA: effect allele, EAF effect allele frequency